SCM
HIMS.WS

Soleus Capital Management’s Hims & Hers Health, Inc. Warrants, each whole warrant exercisable for one Class A Common Stock at an HIMS.WS Stock Holding History

Soleus Capital Management’s Portfolio HIMS.WS Stock Details HIMS.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-91,793
Closed -$404K – 89
2021
Q1 		$404K Buy
+91,793
New +$599K 0.07% 71

Other funds holding HIMS.WS

ICM
Ionic Capital Management New York $690M AUM 70.34% 1-Year Est. Return
AC
Athanor Capital New York $24.6M AUM 2.49% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return
TCMNY
Thrive Capital Management (New York) New York $3.81B AUM 45.58% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
NCM
Narwhal Capital Management Marietta, Georgia $1.45B AUM 28.39% 1-Year Est. Return
CCA
Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return
MP
MSD Partners New York $76.8M AUM 34.91% 1-Year Est. Return

Soleus Capital Management's HIMS.WS Position: Q2 2021 in Review

Soleus Capital Management sold out of Hims & Hers Health, Inc. Warrants, each whole warrant exercisable for one Class A Common Stock at an (HIMS.WS) in Q2 2021, closing a stake of 91,793 shares — an estimated $404K sold.

Soleus Capital Management first reported a position in HIMS.WS in Q1 2021 and held it in 1 quarter. The position peaked at $404K in Q1 2021. 15 funds tracked by Wall St. Rank hold HIMS.WS as of Q2 2021.

  • Soleus Capital Management reported no remaining Hims & Hers Health, Inc. Warrants, each whole warrant exercisable for one Class A Common Stock at an position as of Q2 2021 after selling out during the quarter.
  • Soleus Capital Management sold 91,793 Hims & Hers Health, Inc. Warrants, each whole warrant exercisable for one Class A Common Stock at an shares in Q2 2021, an estimated $404K.
  • Soleus Capital Management first reported a position in Hims & Hers Health, Inc. Warrants, each whole warrant exercisable for one Class A Common Stock at an in Q1 2021 and held it in 1 quarter.
  • Soleus Capital Management's Hims & Hers Health, Inc. Warrants, each whole warrant exercisable for one Class A Common Stock at an position peaked at $404K in Q1 2021.
  • 15 funds tracked by Wall St. Rank held Hims & Hers Health, Inc. Warrants, each whole warrant exercisable for one Class A Common Stock at an as of Q2 2021.

Based on Soleus Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.